Arcutis Biotherapeutics's total assets for Q1 2025 were $344.11M, a decrease of -1.37% from the previous quarter. ARQT total liabilities were $201.45M for the fiscal quarter, a 5.28% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.